Ceribell CBLL
NASDAQ CBLL
$24.20 -0.11 (-0.45%)
At close: Aug 21, 2026 · 4:00 PM EDT

Ceribell (CBLL) Net Income towards Common Stockholders (2023 - 2026)

Ceribell's (CBLL) quarterly Net Income towards Common Stockholders came in at -$19.7 million in Q1 2026, down 54.47% YoY from -$43.4 million in Q1 2025, and down 45.91% on a QoQ basis from -$13.5 million in Q4 2025.

Ceribell (CBLL) Net Income towards Common Stockholders (2023 - 2026) Analysis & Trends

Ceribell (CBLL) has 4 years of Net Income towards Common Stockholders data on file, last reported at -$19.7 million in Q1 2026.

  • Quarterly Net Income towards Common Stockholders fell 54.47% year-over-year to -$19.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$60.4 million (down 35.03% YoY) and the FY2025 annual result came in at -$54.0 million, down 69.15% from the prior year.
  • Net Income towards Common Stockholders fell to -$19.7 million in Q1 2026, from -$13.5 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$7.1 million in Q3 2023 to a low of -$19.7 million in Q1 2026.
  • A 4-year average of -$11.7 million and a median of -$12.6 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2025 — Net Income towards Common Stockholders slipped 7.56% — and 2026, when it tumbled 54.47%.
  • Tracing CBLL's Net Income towards Common Stockholders over 4 years: stood at -$8.3 million in 2023, then sank by 51.99% to -$12.6 million in 2024, then decreased by 7.56% to -$13.5 million in 2025, then slumped by 45.91% to -$19.7 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$19.7 million (Q1 2026), -$13.5 million (Q4 2025), and -$13.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 928.00 Mn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 1.28 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 241.40 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 621.86 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 201.00 Mn
10 Ceribell 916.57 Mn 787.31 Mn 25.94 Mn -19.27 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.27 Mn
Mar 31, 2026 -19.74 Mn
Dec 31, 2025 -13.53 Mn
Sep 30, 2025 -13.47 Mn
Jun 30, 2025 -13.64 Mn
Mar 31, 2025 -12.78 Mn
Dec 31, 2024 -12.58 Mn
Sep 30, 2024 -10.42 Mn
Jun 30, 2024 -8.94 Mn
Mar 31, 2024 -8.52 Mn
Dec 31, 2023 -8.27 Mn
Sep 30, 2023 -7.05 Mn